Insufficient scRNA-seq data for expression of IL12A at single-cell level.
Insufficient scRNA-seq data for expression of IL12A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 94% | 66.61 | 2481 / 2642 | 91% | 3.34 | 640 / 705 |
| ovary | 88% | 29.38 | 158 / 180 | 76% | 3.50 | 327 / 430 |
| lung | 97% | 193.40 | 560 / 578 | 50% | 1.22 | 580 / 1155 |
| intestine | 98% | 71.13 | 951 / 966 | 36% | 0.70 | 191 / 527 |
| esophagus | 94% | 146.26 | 1363 / 1445 | 38% | 0.88 | 70 / 183 |
| uterus | 73% | 34.35 | 124 / 170 | 44% | 1.75 | 202 / 459 |
| breast | 78% | 36.97 | 357 / 459 | 31% | 1.04 | 350 / 1118 |
| pancreas | 85% | 30.85 | 278 / 328 | 23% | 0.41 | 41 / 178 |
| stomach | 68% | 39.26 | 244 / 359 | 36% | 0.74 | 103 / 286 |
| spleen | 100% | 137.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| thymus | 82% | 26.79 | 537 / 653 | 7% | 0.26 | 41 / 605 |
| bladder | 57% | 23.81 | 12 / 21 | 26% | 0.80 | 133 / 504 |
| prostate | 78% | 26.91 | 192 / 245 | 2% | 0.04 | 11 / 502 |
| heart | 78% | 28.33 | 670 / 861 | 0% | 0 | 0 / 0 |
| kidney | 65% | 20.87 | 58 / 89 | 6% | 0.09 | 52 / 901 |
| adipose | 67% | 21.30 | 808 / 1204 | 0% | 0 | 0 / 0 |
| skin | 49% | 37.90 | 884 / 1809 | 17% | 0.40 | 82 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 2.43 | 17 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 1.59 | 22 / 45 |
| adrenal gland | 12% | 2.95 | 31 / 258 | 29% | 1.41 | 67 / 230 |
| peripheral blood | 35% | 69.77 | 321 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 23% | 5.27 | 312 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 22% | 5.04 | 173 / 803 | 0% | 0 | 0 / 0 |
| liver | 9% | 1.53 | 20 / 226 | 8% | 0.16 | 33 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
| GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
| GO_0051135 | Biological process | positive regulation of NK T cell activation |
| GO_1903588 | Biological process | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO_0045954 | Biological process | positive regulation of natural killer cell mediated cytotoxicity |
| GO_0032946 | Biological process | positive regulation of mononuclear cell proliferation |
| GO_0009615 | Biological process | response to virus |
| GO_0045785 | Biological process | positive regulation of cell adhesion |
| GO_0050709 | Biological process | negative regulation of protein secretion |
| GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
| GO_0010224 | Biological process | response to UV-B |
| GO_0034393 | Biological process | positive regulation of smooth muscle cell apoptotic process |
| GO_0006955 | Biological process | immune response |
| GO_0098586 | Biological process | cellular response to virus |
| GO_2000510 | Biological process | positive regulation of dendritic cell chemotaxis |
| GO_0050830 | Biological process | defense response to Gram-positive bacterium |
| GO_0050671 | Biological process | positive regulation of lymphocyte proliferation |
| GO_0032816 | Biological process | positive regulation of natural killer cell activation |
| GO_0048662 | Biological process | negative regulation of smooth muscle cell proliferation |
| GO_0035722 | Biological process | interleukin-12-mediated signaling pathway |
| GO_1900747 | Biological process | negative regulation of vascular endothelial growth factor signaling pathway |
| GO_0002860 | Biological process | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO_0032729 | Biological process | positive regulation of type II interferon production |
| GO_0032700 | Biological process | negative regulation of interleukin-17 production |
| GO_0016477 | Biological process | cell migration |
| GO_0032496 | Biological process | response to lipopolysaccharide |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0031906 | Cellular component | late endosome lumen |
| GO_0043514 | Cellular component | interleukin-12 complex |
| GO_0045513 | Molecular function | interleukin-27 binding |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0042163 | Molecular function | interleukin-12 beta subunit binding |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0005143 | Molecular function | interleukin-12 receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | IL12A |
| Protein name | Interleukin-12 subunit alpha (IL-12A) Interleukin-12 subunit alpha (IL-12A) (Cytotoxic lymphocyte maturation factor 35 kDa subunit) (CLMF p35) (IL-12 subunit p35) (NK cell stimulatory factor chain 1) (NKSF1) |
| Synonyms | hCG_1685939 NKSF1 |
| Description | FUNCTION: Heterodimerizes with IL12B to form the IL-12 cytokine or with EBI3/IL27B to form the IL-35 cytokine . IL-12 is primarily produced by professional antigen-presenting cells (APCs) such as B-cells and dendritic cells (DCs) as well as macrophages and granulocytes and regulates T-cell and natural killer-cell responses, induces the production of interferon-gamma (IFN-gamma), favors the differentiation of T-helper 1 (Th1) cells and is an important link between innate resistance and adaptive immunity . Mechanistically, exerts its biological effects through a receptor composed of IL12R1 and IL12R2 subunits . Binding to the receptor results in the rapid tyrosine phosphorylation of a number of cellular substrates including the JAK family kinases TYK2 and JAK2 . In turn, recruited STAT4 gets phosphorylated and translocates to the nucleus where it regulates cytokine/growth factor responsive genes . As part of IL-35, plays essential roles in maintaining the immune homeostasis of the liver microenvironment and functions also as an immune-suppressive cytokine (By similarity). Mediates biological events through unconventional receptors composed of IL12RB2 and gp130/IL6ST heterodimers or homodimers . Signaling requires the transcription factors STAT1 and STAT4, which form a unique heterodimer that binds to distinct DNA sites . . FUNCTION: Heterodimerizes with IL12B to form the IL-12 cytokine or with EBI3/IL27B to form the IL-35 cytokine. IL-12 is primarily produced by professional antigen-presenting cells (APCs) such as B-cells and dendritic cells (DCs) as well as macrophages and granulocytes and regulates T-cell and natural killer-cell responses, induces the production of interferon-gamma (IFN-gamma), favors the differentiation of T-helper 1 (Th1) cells and is an important link between innate resistance and adaptive immunity. Mechanistically, exerts its biological effects through a receptor composed of IL12R1 and IL12R2 subunits. Binding to the receptor results in the rapid tyrosine phosphorylation of a number of cellular substrates including the JAK family kinases TYK2 and JAK2. In turn, recruited STAT4 gets phosphorylated and translocates to the nucleus where it regulates cytokine/growth factor responsive genes. As part of IL-35, plays essential roles in maintaining the immune homeostasis of the liver microenvironment and functions also as an immune-suppressive cytokine. Mediates biological events through unconventional receptors composed of IL12RB2 and gp130/IL6ST heterodimers or homodimers. Signaling requires the transcription factors STAT1 and STAT4, which form a unique heterodimer that binds to distinct DNA sites. . FUNCTION: Heterodimerizes with IL12B to form the IL-12 cytokine or with EBI3/IL27B to form the IL-35 cytokine. IL-12 is primarily produced by professional antigen-presenting cells (APCs) such as B-cells and dendritic cells (DCs) as well as macrophages and granulocytes and regulates T-cell and natural killer-cell responses, induces the production of interferon-gamma (IFN-gamma), favors the differentiation of T-helper 1 (Th1) cells and is an important link between innate resistance and adaptive immunity. Mechanistically, exerts its biological effects through a receptor composed of IL12R1 and IL12R2 subunits. Binding to the receptor results in the rapid tyrosine phosphorylation of a number of cellular substrates including the JAK family kinases TYK2 and JAK2. In turn, recruited STAT4 gets phosphorylated and translocates to the nucleus where it regulates cytokine/growth factor responsive genes. As part of IL-35, plays essential roles in maintaining the immune homeostasis of the liver microenvironment and functions also as an immune-suppressive cytokine. Mediates biological events through unconventional receptors composed of IL12RB2 and gp130/IL6ST heterodimers or homodimers. Signaling requires the transcription factors STAT1 and STAT4, which form a unique heterodimer that binds to distinct DNA sites. . FUNCTION: Heterodimerizes with IL12B to form the IL-12 cytokine or with EBI3/IL27B to form the IL-35 cytokine. IL-12 is primarily produced by professional antigen-presenting cells (APCs) such as B-cells and dendritic cells (DCs) as well as macrophages and granulocytes and regulates T-cell and natural killer-cell responses, induces the production of interferon-gamma (IFN-gamma), favors the differentiation of T-helper 1 (Th1) cells and is an important link between innate resistance and adaptive immunity. Mechanistically, exerts its biological effects through a receptor composed of IL12R1 and IL12R2 subunits. Binding to the receptor results in the rapid tyrosine phosphorylation of a number of cellular substrates including the JAK family kinases TYK2 and JAK2. In turn, recruited STAT4 gets phosphorylated and translocates to the nucleus where it regulates cytokine/growth factor responsive genes. As part of IL-35, plays essential roles in maintaining the immune homeostasis of the liver microenvironment and functions also as an immune-suppressive cytokine. Mediates biological events through unconventional receptors composed of IL12RB2 and gp130/IL6ST heterodimers or homodimers. Signaling requires the transcription factors STAT1 and STAT4, which form a unique heterodimer that binds to distinct DNA sites. . |
| Accessions | ENST00000305579.7 ENST00000699704.1 ENST00000480787.5 E7ENE1 P29459 O60595 ENST00000466512.1 E9PGR3 |